J-Long Group Limited — Form 6-K Summary
Business Context and Reporting Period
J-Long Group Limited, a Hong Kong-based foreign private issuer, filed Form 6-K on May 17, 2024. The filing reports a Nasdaq continued-listing deficiency notice received on May 13, 2024. It does not present operating or financial results for a specified reporting period.
Financial Metrics and Liquidity
The filing does not provide revenue, profit, cash flow, margins, debt, liquidity, or other financial metrics. It also does not disclose any financial impact from the listing deficiency.
Material Changes and Listing Status
- Nasdaq notified the Company that the closing bid price of its ordinary shares had remained below $1.00 for 30 consecutive business days, violating Nasdaq Listing Rule 5450(a)(2).
- The deficiency notice had no immediate effect on the listing. The shares continued to trade without interruption on The Nasdaq Global Market under the symbol “JL.”
- The Company has until November 11, 2024, to regain compliance.
- Compliance may be regained if the closing bid price reaches at least $1.00 for a minimum of 10 consecutive business days, subject to written confirmation from Nasdaq.
Outlook, Risks, and Contingencies
- If compliance is not restored by November 11, 2024, the Company may be eligible for an additional 180-day compliance period, subject to Nasdaq requirements, an online transfer application, and a non-refundable $5,000 fee.
- During any additional period, the Company would need to satisfy applicable continued-listing requirements, including requirements concerning the market value of publicly held ordinary shares and other initial listing standards, excluding the minimum bid price requirement.
- The Company would also need to notify Nasdaq of its intent to cure the deficiency through a reverse stock split, if necessary.
- Management stated that it will monitor the closing bid price and consider available options, but cautioned that there can be no assurance that compliance will be regained.
Key Facts for Investors to Verify
- Whether the ordinary shares regain a closing bid price of at least $1.00 for 10 consecutive business days before November 11, 2024.
- Whether the Company applies for and qualifies for an additional compliance period if required.
- Whether the Company pursues a reverse stock split or another corrective action.
- Any subsequent Nasdaq notices concerning continued listing, suspension, or delisting.
- The filing’s exhibits, including the May 13, 2024 Nasdaq letter and the Company’s May 16, 2024 press release.